A detailed history of Royal Bank Of Canada transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Royal Bank Of Canada holds 100 shares of HCM stock, worth $1,427. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Previous 266 62.41%
Holding current value
$1,427
Previous $4,000 75.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$16.03 - $20.31 $2,660 - $3,371
-166 Reduced 62.41%
100 $1,000
Q2 2024

Aug 14, 2024

BUY
$16.36 - $21.78 $2,666 - $3,550
163 Added 158.25%
266 $4,000
Q1 2024

Nov 05, 2024

SELL
$12.08 - $18.56 $1,969 - $3,025
-163 Reduced 61.28%
103 $1,000
Q1 2024

May 15, 2024

SELL
$12.08 - $18.56 $4,022 - $6,180
-333 Reduced 76.38%
103 $1,000
Q4 2023

Feb 14, 2024

SELL
$16.25 - $20.23 $66,917 - $83,307
-4,118 Reduced 90.43%
436 $7,000
Q3 2023

Nov 14, 2023

BUY
$11.85 - $16.95 $2,844 - $4,068
240 Added 5.56%
4,554 $77,000
Q2 2023

Aug 14, 2023

SELL
$10.78 - $17.73 $66,846 - $109,943
-6,201 Reduced 58.97%
4,314 $51,000
Q1 2023

May 15, 2023

SELL
$13.02 - $19.87 $55,894 - $85,301
-4,293 Reduced 28.99%
10,515 $136,000
Q4 2022

Feb 14, 2023

BUY
$7.65 - $15.51 $11,268 - $22,846
1,473 Added 11.05%
14,808 $218,000
Q3 2022

Nov 14, 2022

SELL
$8.63 - $15.52 $701,791 - $1.26 Million
-81,320 Reduced 85.91%
13,335 $117,000
Q2 2022

Aug 15, 2022

SELL
$8.59 - $20.77 $337,922 - $817,071
-39,339 Reduced 29.36%
94,655 $1.2 Million
Q1 2022

May 16, 2022

BUY
$15.52 - $35.65 $126,068 - $289,584
8,123 Added 6.45%
133,994 $2.53 Million
Q4 2021

Feb 14, 2022

BUY
$28.89 - $35.33 $143,236 - $175,166
4,958 Added 4.1%
125,871 $4.42 Million
Q3 2021

Nov 15, 2021

BUY
$35.66 - $42.94 $472,031 - $568,396
13,237 Added 12.29%
120,913 $4.43 Million
Q2 2021

Aug 16, 2021

BUY
$23.7 - $39.27 $2.55 Million - $4.23 Million
107,676 New
107,676 $4.23 Million

Others Institutions Holding HCM

About HUTCHMED (China) Ltd


  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $2.47B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.